The Yin and Yang of human beta-defensins in health and disease

Frontiers in Immunology

Volumn 3, Issue OCT, 2012, Pages

  Weinberg, Aaron ^a   Jin, Ge ^a   Sieg, Scott ^b   McCormick, Thomas S ^b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Carcinoma; Epithelial cells; Gingiva; Human beta defensins; Monocytes

Indexed keywords

EID: 84874205028     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00294     Document Type: Review

References (91)

1. Abiko, Y., Mitamura, J., Nishimura, M., Muramatsu, T., Inoue, T., Shimono, M., et al. (1999). Pattern of expression of beta-defensins in oral squamous cell carcinoma. Cancer Lett. 143, 37-43.
2. Abiko, Y., Suraweera, A. K., Nishimura, M., Arakawa, T., Takuma, T., Mizoguchi, I., et al. (2001). Differential expression of human betadefensin 2 in keratinized and nonkeratinized oral epithelial lesions; immunohistochemistry and in situ hybridization. Virchows Arch. 438, 248-253.
3. Alexopoulou, L., Thomas, V., Schnare, M., Lobet, Y., Anguita, J., Schoen, R. T., et al. (2002). Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1and TLR2-deficient mice. Nat. Med. 8, 878-884.
4. Allavena, P., Sica, A., Solinas, G., Porta, C., and Mantovani, A. (2008). The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit. Rev. Oncol. Hematol. 66, 1-9.
5. Biragyn, A., Ruffini, P. A., Leifer, C. A., Klyushnenkova, E., Shakhov, A., Chertov, O., et al. (2002). Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 298, 1025-1029.
6. Biragyn, A., Surenhu, M., Yang, D., Ruffini, P. A., Haines, B. A., Klyushnenkova, E., et al. (2001). Mediators of innate immunity that target immature, but not mature, dendritic cells induce antitumor immunity when genetically fused with nonimmunogenic tumor antigens. J. Immunol. 167, 6644-6653.
7. Biswas, S. K., Sica, A., and Lewis, C. E. (2008). Plasticity of macrophage function during tumor progression: regulation by distinct molecular mechanisms. J. Immunol. 180, 2011-2017.
8. Boe, R., Silvola, J., Yang, J., Moens, U., McCray, P. B., Stenfors, L. E. Jr., et al. (1999). Human beta-defensin-1 mRNA is transcribed in tympanic membrane and adjacent auditory canal epithelium. Infect. Immun. 67, 4843-4846.
9. Boughan, P. K., Argent, R. H., BodyMalapel, M., Park, J. H., Ewings, K. E., Bowie, A. G., et al. (2006). Nucleotidebinding oligomerization domain-1 and epidermal growth factor receptor: critical regulators of beta-defensins during Helicobacter pylori infection. J. Biol. Chem. 281, 11637-11648.
10. Brogden, K. A., Heidari, M., Sacco, R. E., Palmquist, D., Guthmiller, J. M., Johnson, G. K., et al. (2003). Defensininduced adaptive immunity in mice and its potential in preventing periodontal disease. Oral Microbiol. Immunol. 18, 95-99.
11. Buelens, C., Willems, F., Delvaux, A., Pierard, G., Delville, J. P., Velu, T., et al. (1995). Interleukin-10 differentially regulates B7-1 (CD80) and B7-2 (CD86) expression on human peripheral blood dendritic cells. Eur. J. Immunol. 25, 2668-2672.
12. Caramalho, I., Lopes-Carvalho, T., Ostler, D., Zelenay, S., Haury, M., and Demengeot, J. (2003). Regulatory T cells selectively express tolllike receptors and are activated by lipopolysaccharide. J. Exp. Med. 197, 403-411.
13. Casella,C. R.,and Mitchell,T. C. (2008). Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant. Cell. Mol. Life Sci. 65, 3231-3240.
14. Chang, C. H., Furue, M., and Tamaki, K. (1995). B7-1 expression of Langerhans cells is up-regulated by proinflammatory cytokines, and is downregulated by interferon-gamma or by interleukin-10. Eur. J. Immunol. 25, 394-398.
15. Cheng, C., Jain, P., Bettahi, I., Pal, S., Tifrea, D., and de la Maza, L. M. (2011). A TLR2 agonist is a more effective adjuvant for a Chlamydia major outer membrane protein vaccine than ligands to other TLR and NOD receptors. Vaccine 29, 6641-6649.
16. Chung, W. O., and Dale, B. A. (2008). Differential utilization of nuclear factor-kappaB signaling pathways for gingival epithelial cell responses to oral commensal and pathogenic bacteria. Oral Microbiol. Immunol. 23, 119-126.
17. Conejo-Garcia, J. R., Benencia, F., Courreges, M. C., Kang, E., MohamedHadley, A., Buckanovich, R. J., et al. (2004). Tumor-infiltrating dendritic cell precursors recruited by a betadefensin contribute to vasculogenesis under the influence of Vegf-A. Nat. Med. 10, 950-958.
18. Dale, B. A., Kimball, J. R., Krisanaprakornkit, S., Roberts, F., Robinovitch, M., O'Neal, R., et al. (2001). Localized antimicrobial peptide expression in human gingiva. J. Periodont. Res. 36, 285-294.
19. De, Y., Chen, Q., Schmidt, A. P., Anderson, G. M., Wang, J. M., Wooters, J., et al. (2000). LL-37, the neutrophil granuleand epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J. Exp. Med. 192, 1069-1074.
20. de Visser, K. E., Eichten, A., and Coussens, L. M. (2006). Paradoxical roles of the immune system during cancer development. Nat. Rev. Cancer 6, 24-37.
21. Diamond, G., Zasloff, M., Eck, H., Brasseur, M., Maloy, W. L., and Bevins, C. L. (1991). Tracheal antimicrobial peptide, a cysteinerich peptide from mammalian tracheal mucosa: peptide isolation and cloning of a cDNA. Proc. Natl. Acad. Sci. U.S.A. 88, 3952-3956.
22. Duclohier, H. (1994). Anion pores from magainins and related defensive peptides. Toxicology 87, 175-188.
23. Dunsche, A., Acil, Y., Dommisch, H., Siebert, R., Schroder, J. M., and Jepsen, S. (2002). The novel human beta-defensin-3 is widely expressed in oral tissues. Eur. J. Oral Sci. 110, 121-124.
24. Feng, Z., Dubyak, G. R., Lederman, M. M., and Weinberg, A. (2006). Cutting edge: human beta defensin 3 - a novel antagonist of the HIV-1 coreceptor CXCR4. J. Immunol. 177, 782-786.
25. Fiorentino, D. F., Zlotnik,A., Mosmann, T. R., Howard, M., and O'Garra, A. (1991a). IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147, 3815-3822.
26. Fiorentino, D. F., Zlotnik, A., Vieira, P., Mosmann, T. R., Howard, M., Moore, K. W., et al. (1991b). IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146, 3444-3451.
27. Funderburg, N., Lederman, M. M., Feng, Z., Drage, M. G., Jadlowsky, J., Harding, C. V., et al. (2007). Human -defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2. Proc. Natl. Acad. Sci. U.S.A. 104, 18631-18635.
28. Funderburg, N. T., Jadlowsky, J. K., Lederman, M. M., Feng, Z., Weinberg, A., and Sieg, S. F. (2011). The Tolllike receptor 1/2 agonists Pam(3) CSK(4) and human beta-defensin-3 differentially induce interleukin10 and nuclear factor-kappaB signalling patterns in human monocytes. Immunology 134, 151-160.
29. Ganz, T. (2002). Immunology. Versatile defensins. Science 298, 977-979.
30. Garcia, J. R., Jaumann, F., Schulz, S., Krause, A., Rodriguez-Jimenez, J., Forssmann, U., et al. (2001). Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res. 306, 257-264.
31. Ghosh,S. K.,Gerken,T.A.,Schneider,K. M., Feng, Z., McCormick, T. S., and Weinberg, A. (2007). Quantification of human beta-defensin-2 and -3 in body fluids: application for studies of innate immunity. Clin. Chem. 53, 757-765.
32. Gupta, S., Ghosh, S. K., Scott, M. E., Bainbridge, B., Jiang, B., Lamont, R. J., et al. (2010). Fusobacterium nucleatum-associated beta-defensin inducer (FAD-I): identification, isolation, and functional evaluation. J. Biol. Chem. 285, 36523-36531.
33. Hancock, R. E., Brown, K. L., and Mookherjee, N. (2006). Host defence peptides from invertebrates - emerging antimicrobial strategies. Immunobiology 211, 315-322.
34. Harder, J., Bartels, J., Christophers, E., and Schroder,J. M. (1997).A peptide antibiotic from human skin. Nature 387, 861.
35. Harder, J., Bartels, J., Christophers, E., and Schroder, J. M. (2001). Isolation and characterization of human betadefensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 276, 5707-5713.
36. Harder, J., and Schroder, J. M. (2002). RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin. J. Biol. Chem. 277, 46779-46784.
37. Haynes, R. J., McElveen, J. E., Dua, H. S., Tighe, P. J., and Liversidge, J. (2000). Expression of human beta-defensins in intraocular tissues. Invest. Ophthalmol. Vis. Sci. 41, 3026-3031.
38. Hoover, D. M., Chertov, O., and Lubkowski, J. (2001). The structure of human beta-defensin-1. New insights into structural properties of beta-defensins. J. Biol. Chem. 276, 39021-39026.
39. Hoover, D. M., Rajashankar, K. R., Blumenthal, R., Puri, A., Oppenheim, J. J., Chertov, O., et al. (2000). The structure of human beta-defensin2 shows evidence of higher order oligomerization. J. Biol. Chem. 275, 32911-32918.
40. Jin, G., Kawsar, H. I., Hirsch, S. A., Zeng, C., Jia, X., Feng, Z., et al. (2010). An antimicrobial peptide regulates tumor-associated macrophage trafficking via the chemokine receptor CCR2, a model for tumorigenesis. PLoS ONE 5, e10993. doi:10.1371/journal.pone.0010993
41. Jurevic, R. J., Bai, M., Chadwick, R. B., White, T. C., and Dale, B. A. (2003). Single-Nucleotide Polymorphisms (SNPs) in human betadefensin 1: high-throughput snp assays and association with Candida carriage in type I diabetics and nondiabetic controls. J. Clin. Microbiol. 41, 90-96.
42. Kawsar, H. I., Ghosh, S. K., Hirsch, S. A., Koon, H. B., Weinberg, A., and Jin, G. (2010). Expression of human beta-defensin-2 in intratumoral vascular endothelium and in endothelial cells induced by transforming growth factor beta. Peptides 31, 195-201.
43. Kawsar, H. I., Weinberg, A., Hirsch, S. A., Venizelos, A., Howell, S., Jiang, B., et al. (2009). Overexpression of human beta-defensin-3 in oral dysplasia: potential role in macrophage trafficking. Oral Oncol. 45, 50-56.
44. Kesting, M. R., Loeffelbein, D. J., Hasler, R. J., Wolff, K. D., Rittig, A., Schulte, M., et al. (2009). Expression profile of human beta-defensin 3 in oral squamous cell carcinoma. Cancer Invest. 27, 575-581.
45. Kohlgraf, K. G., Ackermann, A., Lu, X., Burnell, K., Belanger, M., Cavanaugh, J. E., et al. (2010a). Defensins attenuate cytokine responses yet enhance antibody responses to Porphyromonas gingivalis adhesins in mice. Future Microbiol. 5, 115-125.
46. Kohlgraf, K. G., Pingel, L. C., Dietrich, D. E., and Brogden, K. A. (2010b). Defensins as anti-inflammatory compounds and mucosal adjuvants. Future Microbiol. 5, 99-113.
47. Kopp,E.,and Medzhitov,R. (2002). Skin antibiotics get in the loop. Nat. Med. 8, 1359-1360.
48. Krisanaprakornkit, S., Kimball, J. R., Weinberg, A., Darveau, R. P., Bainbridge, B. W., and Dale, B. A. (2000). Inducible expression of human betadefensin 2 by Fusobacterium nucleatum in oral epithelial cells: multiple signaling pathways and role of commensal bacteria in innate immunity and the epithelial barrier. Infect. Immun. 68, 2907-2915.
49. Krisanaprakornkit, S., Weinberg, A., Perez, C. N., and Dale. B. A. (1998). Expression of the peptide antibiotic human beta-defensin 1 in cultured gingival epithelial cells and gingival tissue. Infect. Immun. 66,4222-4228.
50. Lee, C. H., Masso-Welch, P., Hajishengallis, G., and Connell, T. D. (2011). TLR2-dependent modulation of dendritic cells by LT-IIa-B5, a novel mucosal adjuvant derived from a type II heat-labile enterotoxin. J. Leukoc. Biol. 90, 911-921.
51. Lee, S. H., Jun, H. K., Lee, H. R., Chung, C. P., and Choi, B. K. (2010). Antibacterial and lipopolysaccharide (LPS)-neutralising activity of human cationic antimicrobial peptides against periodontopathogens. Int. J. Antimicrob. Agents 35, 138-145.
52. Lu, Q., Samaranayake, L. P., Darveau, R. P., and Jin, L. (2005). Expression of human beta-defensin-3 in gingival epithelia. J. Periodont. Res. 40, 474-481.
53. Luger, T. A., Scholzen, T. E., Brzoska, T., and Bohm, M. (2003). New insights into the functions of alpha-MSH and related peptides in the immune system. Ann. N. Y. Acad. Sci. 994, 133-140.
54. Mata-Haro, V., Cekic, C., Martin, M., Chilton, P. M., Casella, C. R., and Mitchell, T. C. (2007). The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4. Science 316, 1628-1632.
55. McCray, P. B. Jr., and Bentley, L. (1997). Human airway epithelia express a beta-defensin. Am. J. Respir. Cell Mol. Biol. 16, 343-349.
56. Mei, H. F., Jin, X. B., Zhu, J. Y., Zeng, A. H., Wu, Q., Lu, X., et al. (2012). Beta-defensin 2 as an adjuvant promotes anti-melanoma immune responses and inhibits the growth of implanted murine melanoma in vivo. PLoS ONE 7, e31328. doi:10.1371/journal.pone.0031328
57. Mizukawa, N., Sawaki, K., Nagatsuka, H., Kamio, M., Yamachika, E., Fukunaga, J., et al. (2001). Human alphaand beta-defensin immunoreactivity in oral mucoepidermoid carcinomas. Anticancer Res. 21, 2171-2174.
58. Mizukawa, N., Sawaki, K., Yamachika, E., Fukunaga, J., Ueno, T., Takagi, S., et al. (2000). Presence of human beta-defensin-2 in oral squamous cell carcinoma. Anticancer Res. 20, 2005-2007.
59. Mottonen, M., Isomaki, P., Saario, R., Toivanen, P., Punnonen, J., and Lassila, O. (1998). Interleukin-10 inhibits the capacity of synovial macrophages to function as antigenpresenting cells. Br. J. Rheumatol. 37, 1207-1214.
60. Nagaoka, I., Hirota, S., Niyonsaba, F., Hirata, M., Adachi, Y., Tamura, H., et al. (2001). Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-alpha by blocking the binding of LPS to CD14(+) cells. J. Immunol. 167, 3329-3338.
61. Netea, M. G., Sutmuller, R., Hermann, C., van der Graaf, C. A., van der Meer, J. W., van Krieken, J. H., et al. (2004). Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J. Immunol. 172, 3712-3718.
62. O'Neil, D. A., Porter, E. M., Elewaut, D., Anderson, G. M., Eckmann, L., Ganz, T., et al. (1999). Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium. J. Immunol. 163, 6718-6724.
63. Pantelis, A., Wenghoefer, M., Haas, S., Merkelbach-Bruse, S., Pantelis, D., Jepsen, S., et al. (2009). Down regulation and nuclear localization of human beta-defensin-1 in pleomorphic adenomas of salivary glands. Oral Oncol. 45, 526-530.
64. Pazgier, M., Hoover, D. M., Yang, D., Lu, W., and Lubkowski, J. (2006). Human beta-defensins. Cell. Mol. Life Sci. 63, 1294-1313.
65. Pollard, J. W. (2004). Tumoureducated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 4, 71-78.
66. Pore, D., Mahata, N., and Chakrabarti, M. K. (2012). Outer membrane protein A (OmpA) of Shigella flexneri 2a links innate and adaptive immunity in a TLR2-dependent manner and involvement of IL-12 and nitric oxide. J. Biol. Chem. 287, 12589-12601.
67. Quinones-Mateu, M. E., Lederman, M. M., Feng, Z., Chakraborty, B.,Weber, J., Rangel, H.R., etal.(2003).Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication. AIDS 17, F39-F48.
68. Rodriguez-Jimenez, F. J., Krause, A., Schulz, S., Forssmann, W. G., Conejo-Garcia, J. R., Schreeb, R., et al. (2003). Distribution of new human beta-defensin genes clustered on chromosome 20 in functionally different segments of epididymis. Genomics 81, 175-183.
69. Rohrl, J., Yang, D., Oppenheim, J. J., and Hehlgans, T. (2008). Identification and biological characterization of mouse beta-defensin 14, the orthologue of human beta-defensin 3. J. Biol. Chem. 283, 5414-5419.
70. Rohrl, J., Yang, D., Oppenheim, J. J., and Hehlgans, T. (2010). Human beta-defensin 2 and 3 and their mouse orthologs induce chemotaxis through interaction with CCR2. J. Immunol. 184, 6688-6694.
71. Salkowski, C. A., Detore, G. R., and Vogel, S. N. (1997). Lipopolysaccharide and monophosphoryl lipid A differentially regulate interleukin-12, gamma interferon, and interleukin-10 mRNA production in murine macrophages. Infect. Immun. 65, 3239-3247.
72. Sawaki, K., Mizukawa, N., Yamaai, T., Yoshimoto, T., Nakano, M., and Sugahara, T. (2002). High concentration of beta-defensin-2 in oral squamous cell carcinoma. Anticancer Res. 22, 2103-2107.
73. Schonwetter, B. S., Stolzenberg, E. D., and Zasloff, M. A. (1995). Epithelial antibiotics induced at sites of inflammation. Science 267, 1645-1648.
74. Schroder, J. M., and Harder, J. (1999). Human beta-defensin-2. Int. J. Biochem. Cell Biol. 31, 645-651.
75. Schutte, B. C., Mitros, J. P., Bartlett, J. A., Walters, J. D., Jia, H. P., Welsh, M. J., et al. (2002). Discovery of five conserved beta-defensin gene clusters using a computational search strategy. Proc. Natl. Acad. Sci. U.S.A. 99, 2129-2133.
76. Scott, A., Weldon, S., Buchanan, P. J., Schock, B., Ernst, R. K., McAuley, D. F., et al. (2011). Evaluation of the ability of LL-37 to neutralise LPS in vitro and ex vivo. PLoS ONE 6, e26525. doi:10.1371/journal.pone. 0026525
77. Semple, F., Webb, S., Li, H. N., Patel, H. B., Perretti, M., Jackson, I. J., et al. (2010). Human beta-defensin 3 has immunosuppressive activity in vitro and in vivo. Eur. J. Immunol. 40, 1073-1078.
78. Sorensen, O. E., Cowland, J. B., Theilgaard-Monch, K., Liu, L., Ganz, T., and Borregaard, N. (2003). Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors. J. Immunol. 170, 5583-5589.
79. Sorensen, O. E., Thapa, D. R., Roupe, K. M., Valore, E. V., Sjobring, U., Roberts, A. A., et al. (2006). Injuryinduced innate immune response in human skin mediated by transactivation of the epidermal growth factor receptor. J. Clin. Invest. 116, 1878-1885.
80. Suphasiriroj, W., Mikami, M., Shimomura, H., and Sato, S. (2012). Specificity of antimicrobial peptide LL-37 to neutralize periodontopathogenic lipopolysaccharide activity in human oral fibroblasts. J. Periodontol. PMID: 22443521. [Epub ahead of print].
81. Tani, K., Murphy, W. J., Chertov, O., Salcedo, R., Koh, C. Y., Utsunomiya, I., et al. (2000). Defensins act as potent adjuvants that promote cellular and humoral immune responses in mice to a lymphoma idiotype and carrier antigens. Int. Immunol. 12, 691-700.
82. Taylor, K., Clarke, D. J., McCullough, B., Chin, W., Seo, E., Yang, D., et al. (2008). Analysis and separation of residues important for the chemoattractant and antimicrobial activities of beta-defensin 3. J. Biol. Chem. 283, 6631-6639.
83. Weinberg, A., Krisanaprakornkit, S., and Dale, B. A. (1998). Epithelial antimicrobial peptides: review and significance for oral applications. Crit. Rev. Oral Biol. Med. 9, 399-414.
84. Wenghoefer, M., Pantelis, A., Dommisch, H., Gotz, W., Reich, R., Berge, S., et al. (2008). Nuclear hBD-1 accumulation in malignant salivary gland tumours. BMC Cancer 8, 290. doi:10.1186/1471-2407-8-290
85. Yang, D., Chertov, O., Bykovskaia, S. N., Chen, Q., Buffo, M. J., Shogan, J., et al. (1999). Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286, 525-528.
86. Yang, D., Liu, P., Tewary, Z. H., Chen, Q., de la Rosa, G., and Oppenheim, J. J. (2007). Defensin participation in innate and adaptive immunity. Curr. Pharm. Des. 13, 3131-3139.
87. Yin, L., Chino, T., Horst, O. V., Hacker, B. M., Clark, E. A., Dale, B. A., et al. (2010). Differential and coordinated expression of defensins and cytokines by gingival epithelial cells and dendritic cells in response to oral bacteria. BMC Immunol. 11:37. doi: 10.1186/1471-2172-11-37
88. Young, A. N., de Oliveira Salles, P. G., Lim, S. D., Cohen, C., Petros, J. A., Marshall, F. F., et al. (2003). Beta defensin-1, parvalbumin, and vimentin: a panel of diagnostic immunohistochemical markers for renal tumors derived from gene expression profiling studies using cDNA microarrays. Am. J. Surg. Pathol. 27, 199-205.
89. Zanetti, M. (2004). Cathelicidins, multifunctional peptides of the innate immunity. J. Leukoc. Biol. 75, 39-48.
90. Zasloff, M. (2002). Antimicrobial peptides of multicellular organisms. Nature 415, 389-395.
91. Zhao, C., Wang, I., and Lehrer, R. I. (1996). Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett. 396, 319-322.